Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis
@article{ATM67139,
author = {Xueshan Sun and Xuemei Zhen and Xiaoqian Hu and Yuanyuan Li and Shuyan Gu and Yuxuan Gu and Zixuan Zhao and Wei Yang and Hengjin Dong},
title = {Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis},
journal = {Annals of Translational Medicine},
volume = {9},
number = {7},
year = {2021},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/67139}
}